Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Selected health behaviors moderate the progression of functional limitations in persons with multiple sclerosis: Eleven years of annual follow-up.
Three Minor Diterpenoids with Three Carbon Skeletons from Euphorbia peplus.
T1- vs. T2-based MRI measures of spinal cord volume in healthy subjects and patients with multiple sclerosis.
Smoking Beyond Multiple Sclerosis Diagnosis: A Risk Factor Still Worth Modifying.
NFκB signaling drives pro-granulocytic astroglial responses to neuromyelitis optica patient IgG.
Myeloid cell-based therapies in neurological disorders: How far have we come?
Targeting molecules to medicine with mTOR, autophagy, and neurodegenerative disorders.
How to make an oligodendrocyte.
Fingolimod for the treatment of neurological diseases-state of play and future perspectives.
Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial.
Neutrophil-related factors as biomarkers in EAE and MS.
Electrophysiological Evaluation of Dysphagia in the Mild or Moderate Patients with Multiple Sclerosis: A Concept of Subclinical Dysphagia.
Genetic polymorphisms related to vitamin D and the therapeutic potential of vitamin D in multiple sclerosis.
Improving communication with multiple sclerosis patients.
Generalised cognitive motor interference in multiple sclerosis.
The profile of patients followed at the Neuroimmunology Clinic at UNIFESP: 20 years analysis.
Headache in multiple sclerosis and autoimmune disorders.
Asymptomatic myelitis in neuromyelitis optica and autoimmune aquaporin-4 channelopathy.
Heterogeneous Network Edge Prediction: A Data Integration Approach to Prioritize Disease-Associated Genes.
People with Multiple Sclerosis use many fall prevention strategies but still fall frequently.
Clinically silent PML and prolonged immune reconstitution inflammatory syndrome in a patient with multiple sclerosis treated with natalizumab.
[Optic neuritis--immunological approach to elucidate pathogenesis and develop innovative therapy].
Regulation of oligodendrocyte precursor migration during development, in adulthood and in pathology.
The progress of cognitive decline in newly diagnosed MS patients.
Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.

Pages